Patient understanding, detection, and experience of COPD exacerbations -: An observational, interview-based study

被引:191
作者
Kessler, Romain [1 ]
Stahl, Elisabeth
Vogelmeier, Claus
Haughney, John
Trudeau, Elyse
Lofdahl, Claes-Goran
机构
[1] Hop Univ Strasbourg, Hop Hautpierre, Dept Pulmonol, Strasbourg, France
[2] Univ Aberdeen, Aberdeen, Scotland
[3] Marburg Univ Hosp, Marburg, Germany
[4] Mapi Values, Lyon, France
[5] Univ Lund Hosp, S-22185 Lund, Sweden
[6] Imperial Coll London, London, England
关键词
burden; COPD; exacerbation; patient's perspective;
D O I
10.1378/chest.130.1.133
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Study objectives: This study was conducted to gain insight into patients' comprehension, recognition, and experience of exacerbations of COPD, and to explore the patient burden associated with these events. Design: A qualitative, multinational, cross-sectional, interview-based study. Setting: Patients' homes. Patients: Patients (n = 125) with predominantly moderate-to-very severe COPD (age >= 50 years; with two or more exacerbations during the previous year). Interventions: Patients underwent a 1-h face-to-face interview with a trained interviewer. Measurements and results: During the preceding year, patients experienced a mean +/- SD of 4.6 +/- 5.4 exacerbations, after which 19.2% (n = 24) believed they had not fully recovered. Although commonly used by physicians, only 1.6% (n = 2) of patients understood the term exacerbation, preferring to use simpler terms, such as chest infection (16.0%; n = 20) or crisis (16.0%; n = 20) instead. Approximately two thirds of patients stated that they were aware of when an exacerbation was imminent and, in most cases, patients recounted that symptoms were consistent from one exacerbation to another. Some patients (32.8%; n = 41), however, reported no recognizable warning signs. At the onset of an exacerbation, 32.8% of patients (n = 41) stated that they reacted by self-administering their medication. Some patients spontaneously mentioned a fear of dying (12.0%; n = 15) or suffocating (9.6%; n = 12) during exacerbations, and effects on activities, mood, and personal/family relationships were frequently reported. Physicians tended to underestimate the psychological impact of exacerbations compared with patient reports. Conclusions: This study shows that patients with frequent exacerbations have a poor understanding of the term exacerbation. Patient recollections suggest that exacerbation profiles vary enormously between patients but that symptoms/warning signs are fairly consistent within individuals, and are generally recognizable. Exacerbations appear to have a significant impact on patient well-being, including psychological well-being, and this may be underestimated by physicians.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 36 条
[1]
The impact of exacerbations on the asthmatic patient's preference scores [J].
Andersson, F ;
Borg, S ;
Ståhl, E .
JOURNAL OF ASTHMA, 2003, 40 (06) :615-623
[2]
The costs of exacerbations in chronic obstructive pulmonary disease (COPD) [J].
Andersson, F ;
Borg, S ;
Jansson, SA ;
Jonsson, AC ;
Ericsson, Å ;
Prütz, C ;
Rönmark, E ;
Lundbäck, B .
RESPIRATORY MEDICINE, 2002, 96 (09) :700-708
[3]
Perception of fatigue and quality of life in patients with COPD [J].
Breslin, E ;
van der Schans, C ;
Breukink, S ;
Meek, P ;
Mercer, K ;
Volz, W ;
Louie, S .
CHEST, 1998, 114 (04) :958-964
[4]
COPD exacerbations: definitions and classifications [J].
Burge, S ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 :46S-53S
[5]
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [J].
Calverley, P ;
Pauwels, R ;
Vestbo, J ;
Jones, P ;
Pride, N ;
Gulsvik, A ;
Anderson, J ;
Maden, C .
LANCET, 2003, 361 (9356) :449-456
[6]
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease [J].
Calverley, PM ;
Boonsawat, W ;
Cseke, Z ;
Zhong, N ;
Peterson, S ;
Olsson, H .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :912-919
[7]
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease [J].
Casaburi, R ;
Mahler, DA ;
Jones, PW ;
Wanner, A ;
San Pedro, G ;
ZuWallack, RL ;
Menjoge, SS ;
Serby, CW ;
Witek, T .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) :217-224
[8]
Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967
[9]
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature [J].
Doll, H ;
Miravitlles, M .
PHARMACOECONOMICS, 2005, 23 (04) :345-363
[10]
Quality of life in acute exacerbation of chronic bronchitis: results from a German population study [J].
Doll, H ;
Grey-Amante, P ;
Duprat-Lomon, I ;
Sagnier, PP ;
Thate-Waschke, I ;
Lorenz, J ;
Rychlik, R ;
Pfeil, T .
RESPIRATORY MEDICINE, 2002, 96 (01) :39-51